AGP Executive Report
Last update: 6 hours agoPost-acute EHR Deal: Frazier Healthcare Partners agreed to acquire MatrixCare from Resmed, aiming to invest in cloud EHR software for skilled nursing, senior living, home health, hospice, and life plan communities. Obesity Drug Access Under Scrutiny: A Yale/JAMA secret shopper investigation found many telehealth providers prescribing GLP-1 obesity meds without adequate care, raising fresh regulator concerns about “cavalier” prescribing. Ebola Trial Moves Fast in DRC: First patients were enrolled in a record-speed Ebola treatment trial in the Democratic Republic of the Congo, as the outbreak response continues amid challenges like contact tracing and public trust. Wearables for Heart Risk: New wearable tech can detect hidden heart rhythm disorders and help flag stroke risk by analyzing arrhythmia patterns over time. Mental Health and Medication Culture: A piece questions whether modern psychiatry has over-medicalized human suffering, urging attention to social and structural drivers. Cancer AI Validation: Artera’s multimodal AI prognostic model for early-stage HR+/HER2− breast cancer was validated using pathology slides plus limited clinical data. Diabetes Awareness: Australia’s Lara McSpadden shared her type 1 diabetes story ahead of the Commonwealth Games as part of National Diabetes Week. Public Health Nutrition: Research links higher blood glucose with faster “brain aging” on MRI, adding to evidence that glucose control may matter beyond diabetes and heart disease.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.